{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T15:53:46Z","timestamp":1795017226506,"version":"4.10.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.biomaterials.2021.121233","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T23:24:00Z","timestamp":1635463440000},"page":"121233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"special_numbering":"C","title":["Synergistic photothermal cancer immunotherapy by Cas9 ribonucleoprotein-based copper sulfide nanotherapeutic platform targeting PTPN2"],"prefix":"10.1016","volume":"279","author":[{"given":"Tao","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiruo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiliang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9620-7502","authenticated-orcid":false,"given":"Xin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biomaterials.2021.121233_bib1","doi-asserted-by":"crossref","first-page":"6517","DOI":"10.1021\/acsnano.0c08790","article-title":"Temperature-sensitive lipid-coated carbon nanotubes for synergistic photothermal therapy and gene therapy","volume":"15","author":"Zhao","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2021.121233_bib2","doi-asserted-by":"crossref","first-page":"120550","DOI":"10.1016\/j.biomaterials.2020.120550","article-title":"Bacteria-derived membrane vesicles to advance targeted photothermal tumor ablation","volume":"268","author":"Zhuang","year":"2021","journal-title":"Biomaterials"},{"issue":"23","key":"10.1016\/j.biomaterials.2021.121233_bib3","doi-asserted-by":"crossref","first-page":"7728","DOI":"10.1002\/anie.201902476","article-title":"Activation of prodrugs by NIR-triggered release of exogenous enzymes for locoregional chemo-photothermal therapy","volume":"58","author":"Cheng","year":"2019","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"4","key":"10.1016\/j.biomaterials.2021.121233_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202004788","article-title":"Recent advances in hyperthermia therapy-based synergistic immunotherapy","volume":"33","author":"Chang","year":"2021","journal-title":"Adv. Mater."},{"issue":"43","key":"10.1016\/j.biomaterials.2021.121233_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202004161","article-title":"A metal-polymer hybrid biomimetic system for use in the chemodynamic-enhanced photothermal therapy of cancers","volume":"16","author":"Kong","year":"2020","journal-title":"Small"},{"key":"10.1016\/j.biomaterials.2021.121233_bib6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jconrel.2020.06.032","article-title":"Photothermal therapy","volume":"325","author":"Zhi","year":"2020","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.biomaterials.2021.121233_bib7","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1038\/s41467-019-11269-8","article-title":"Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death","volume":"10","author":"Li","year":"2019","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.biomaterials.2021.121233_bib8","doi-asserted-by":"crossref","first-page":"6635","DOI":"10.1021\/acs.nanolett.9b02903","article-title":"Intracellularly generated immunological gold nanoparticles for combinatorial photothermal therapy and immunotherapy against tumor","volume":"19","author":"Zhang","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.biomaterials.2021.121233_bib9","doi-asserted-by":"crossref","first-page":"120545","DOI":"10.1016\/j.biomaterials.2020.120545","article-title":"Intelligent MoS2-CuO heterostructures with multiplexed imaging and remarkably enhanced antitumor efficacy via synergetic photothermal therapy\/chemodynamic therapy\/immunotherapy","volume":"268","author":"Jiang","year":"2021","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.biomaterials.2021.121233_bib10","doi-asserted-by":"crossref","first-page":"17442","DOI":"10.1021\/acsnano.0c07721","article-title":"Fighting immune cold and reprogramming immunosuppressive tumor microenvironment with red blood cell membrane-camouflaged nanobullets","volume":"14","author":"Yang","year":"2020","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.biomaterials.2021.121233_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202003458","article-title":"Second near-infrared photothermal semiconducting polymer nanoadjuvant for enhanced cancer immunotherapy","volume":"33","author":"Li","year":"2021","journal-title":"Adv. Mater."},{"issue":"7664","key":"10.1016\/j.biomaterials.2021.121233_bib12","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature23270","article-title":"In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target","volume":"547","author":"Manguso","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biomaterials.2021.121233_bib13","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140281","article-title":"Protein tyrosine phosphatase nonreceptor type 2 controls colorectal cancer development","volume":"131","author":"Katkeviciute","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.biomaterials.2021.121233_bib14","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019103637","article-title":"PTPN2 phosphatase deletion in T cells promotes anti-tumour immunity and CAR T-cell efficacy in solid tumours","volume":"39","author":"Wiede","year":"2020","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.biomaterials.2021.121233_bib15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41589-020-00700-7","article-title":"Controlling and enhancing CRISPR systems","volume":"17","author":"Shivram","year":"2021","journal-title":"Nat. Chem. Biol."},{"issue":"4","key":"10.1016\/j.biomaterials.2021.121233_bib16","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41587-019-0050-1","article-title":"Genome-wide target specificity of CRISPR RNA-guided adenine base editors","volume":"37","author":"Kim","year":"2019","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"10.1016\/j.biomaterials.2021.121233_bib17","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1021\/acs.accounts.9b00106","article-title":"Delivery aspects of CRISPR\/Cas for in vivo genome editing","volume":"52","author":"Wilbie","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.biomaterials.2021.121233_bib18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jconrel.2017.09.012","article-title":"Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications","volume":"266","author":"Liu","year":"2017","journal-title":"J. Contr. Release"},{"issue":"6405","key":"10.1016\/j.biomaterials.2021.121233_bib19","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1126\/science.aat5011","article-title":"CRISPR-Cas guides the future of genetic engineering","volume":"361","author":"Knott","year":"2018","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.biomaterials.2021.121233_bib20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41571-019-0166-8","article-title":"CRISPR-Cas: a tool for cancer research and therapeutics","volume":"16","author":"Yin","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"7853","key":"10.1016\/j.biomaterials.2021.121233_bib21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41586-021-03191-1","article-title":"The NIH somatic cell genome editing program","volume":"592","author":"Saha","year":"2021","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.biomaterials.2021.121233_bib22","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrd.2016.280","article-title":"Delivery technologies for genome editing","volume":"16","author":"Yin","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"15","key":"10.1016\/j.biomaterials.2021.121233_bib23","doi-asserted-by":"crossref","first-page":"9874","DOI":"10.1021\/acs.chemrev.6b00799","article-title":"CRISPR\/Cas9-Based genome editing for disease modeling and therapy: challenges and opportunities for nonviral delivery","volume":"117","author":"Wang","year":"2017","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/j.biomaterials.2021.121233_bib24","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1038\/s41467-020-17029-3","article-title":"Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing","volume":"11","author":"Wei","year":"2020","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.biomaterials.2021.121233_bib25","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/s41591-018-0137-0","article-title":"A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells","volume":"24","author":"Vakulskas","year":"2018","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.biomaterials.2021.121233_bib26","doi-asserted-by":"crossref","first-page":"614","DOI":"10.7150\/thno.47007","article-title":"Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR\/Cas9 genome editing","volume":"11","author":"Zhang","year":"2021","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.biomaterials.2021.121233_bib27","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/anie.201708689","article-title":"Thermo-triggered release of CRISPR-cas9 system by lipid-encapsulated gold nanoparticles for tumor therapy","volume":"57","author":"Wang","year":"2018","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.biomaterials.2021.121233_bib28","doi-asserted-by":"crossref","first-page":"120194","DOI":"10.1016\/j.biomaterials.2020.120194","article-title":"Chlorin e6 and CRISPR-Cas9 dual-loading system with deep penetration for a synergistic tumoral photodynamic-immunotherapy","volume":"255","author":"Yang","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2021.121233_bib29","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.biomaterials.2018.04.031","article-title":"Non-viral delivery systems for CRISPR\/Cas9-based genome editing: challenges and opportunities","volume":"171","author":"Li","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2021.121233_bib30","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2020.06.022","article-title":"Recent advancements in liposome technology","volume":"156","author":"Filipczak","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"7\u20138","key":"10.1016\/j.biomaterials.2021.121233_bib31","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41417-019-0141-7","article-title":"Liposomal delivery of CRISPR\/Cas9","volume":"27","author":"Zhen","year":"2020","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.biomaterials.2021.121233_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2019.11.005","article-title":"Rational designs of in vivo CRISPR-Cas delivery systems","volume":"168","author":"Xu","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2021.121233_bib33","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/s41551-017-0137-2","article-title":"Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair","volume":"1","author":"Lee","year":"2017","journal-title":"Nat. Biomed. Eng."},{"issue":"29","key":"10.1016\/j.biomaterials.2021.121233_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb4005","article-title":"Codelivery of CRISPR-Cas9 and chlorin e6 for spatially controlled tumor-specific gene editing with synergistic drug effects","volume":"6","author":"Deng","year":"2020","journal-title":"Sci. Adv."},{"issue":"4","key":"10.1016\/j.biomaterials.2021.121233_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav7199","article-title":"Near-infrared upconversion-activated CRISPR-Cas9 system: a remote-controlled gene editing platform","volume":"5","author":"Pan","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biomaterials.2021.121233_bib36","doi-asserted-by":"crossref","first-page":"119736","DOI":"10.1016\/j.biomaterials.2019.119736","article-title":"Ultrasound-activated particles as CRISPR\/Cas9 delivery system for androgenic alopecia therapy","volume":"232","author":"Ryu","year":"2020","journal-title":"Biomaterials"},{"issue":"15","key":"10.1016\/j.biomaterials.2021.121233_bib37","doi-asserted-by":"crossref","first-page":"1903441","DOI":"10.1002\/advs.201903441","article-title":"Smart gold nanostructures for light mediated cancer theranostics: combining optical diagnostics with photothermal therapy","volume":"7","author":"Tabish","year":"2020","journal-title":"Adv. Sci."},{"issue":"34","key":"10.1016\/j.biomaterials.2021.121233_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202002672","article-title":"Single-photomolecular nanotheranostics for synergetic near-infrared fluorescence and photoacoustic imaging-guided highly effective photothermal ablation","volume":"16","author":"Xiao","year":"2020","journal-title":"Small"},{"issue":"28","key":"10.1016\/j.biomaterials.2021.121233_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb1777","article-title":"Engineering a far-red light-activated split-Cas9 system for remote-controlled genome editing of internal organs and tumors","volume":"6","author":"Yu","year":"2020","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.biomaterials.2021.121233_bib40","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41551-018-0318-7","article-title":"Spatial control of in vivo CRISPR-Cas9 genome editing via nanomagnets","volume":"3","author":"Zhu","year":"2019","journal-title":"Nat. Biomed. Eng."},{"issue":"50","key":"10.1016\/j.biomaterials.2021.121233_bib41","doi-asserted-by":"crossref","first-page":"18197","DOI":"10.1002\/anie.201909264","article-title":"A photolabile semiconducting polymer nanotransducer for near-infrared regulation of CRISPR\/Cas9 gene editing","volume":"58","author":"Lyu","year":"2019","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"8","key":"10.1016\/j.biomaterials.2021.121233_bib42","doi-asserted-by":"crossref","first-page":"10688","DOI":"10.1021\/acsnano.0c05332","article-title":"Bortezomib-encapsulated CuS\/carbon dot nanocomposites for enhanced photothermal therapy via stabilization of polyubiquitinated substrates in the proteasomal degradation pathway","volume":"14","author":"Yu","year":"2020","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.biomaterials.2021.121233_bib43","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1021\/acs.nanolett.9b01595","article-title":"Intelligent hollow Pt-CuS janus architecture for synergistic catalysis-enhanced sonodynamic and photothermal cancer therapy","volume":"19","author":"Liang","year":"2019","journal-title":"Nano Lett."},{"issue":"24","key":"10.1016\/j.biomaterials.2021.121233_bib44","doi-asserted-by":"crossref","first-page":"7916","DOI":"10.1039\/C8DT01174E","article-title":"DNA decorated Cu9S5 nanoparticles as NIR light responsive drug carriers for tumor chemo-phototherapy","volume":"47","author":"Liang","year":"2018","journal-title":"Dalton Trans."},{"issue":"43","key":"10.1016\/j.biomaterials.2021.121233_bib45","doi-asserted-by":"crossref","first-page":"15351","DOI":"10.1021\/ja106855m","article-title":"A chelator-free multifunctional [64Cu]CuS nanoparticle platform for simultaneous micro-PET\/CT imaging and photothermal ablation therapy","volume":"132","author":"Zhou","year":"2010","journal-title":"J. Am. Chem. Soc."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961221005901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961221005901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:08:16Z","timestamp":1758906496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961221005901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":45,"alternative-id":["S0142961221005901"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2021.121233","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic photothermal cancer immunotherapy by Cas9 ribonucleoprotein-based copper sulfide nanotherapeutic platform targeting PTPN2","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2021.121233","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121233"}}